-what is already known
Bladder cancer is the most common neoplasm of the urinary tract and there are no effective therapies that delay disease recurrence or drug resistance.
IR-780,a near-infrared fluorescent agent,has been reported to have both tumor and mitochondrial targeting properties. However, research on the antitumor effect of IR-780 is limited.